{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T14:38:16Z","timestamp":1794062296102,"version":"4.8.0"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Bilateral Macronodular Adrenocortical Disease (BMAD) is characterized by bilateral benign macronodules and, frequently, autonomous cortisol secretion. Germline molecular alterations of tumor suppressor genes are identified in around 30% of cases, the most frequent being ARMC5. Even if adrenocortical nodular disease often occurs with tumor suppressor gene pathogenic variant, the association with adrenal cortical carcinoma (ACC) is rare and no functional studies have proven a link between these two diseases. We reported the case of a woman with an adrenal Cushing's syndrome developed on BMAD. Over 20 years later, ACC was diagnosed, developed inside a benign nodule of macronodular adrenal gland. Germline genotyping showed no alteration in CDKN1B, KDM1A, PRKACA, PRKAR1A, MEN1, APC, ARMC5, or TP53 genes. Next-generation sequencing has been performed in the ACC and the adjacent macronodular tissue, showing a progressive accumulation of somatic protumoral molecular alterations between the benign nodular part of the adrenal gland and the ACC. Therefore, we hypothesize that BMAD could be an early event of ACC development and may beneficiated from more systematic radiological monitoring.<\/jats:p>","DOI":"10.1093\/ejendo\/lvaf105","type":"journal-article","created":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T11:42:49Z","timestamp":1748518969000},"page":"K55-K59","source":"Crossref","is-referenced-by-count":5,"title":["From hyperplasia to carcinoma: a molecular driven adrenal disease"],"prefix":"10.1093","volume":"192","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-8891-0565","authenticated-orcid":false,"given":"Elisa","family":"Dybal","sequence":"first","affiliation":[{"name":"Endocrinology Department, Reference Centre for Rare Pituitary Diseases HYPO, \u201cGroupement Hospitalier Est\u201d Hospices Civils de Lyon , 69500 Bron ,","place":["France"]},{"name":"Lyon 1 University, Claude Bernard University \u00a0 Medical School, 69003 Lyon ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Decaussin-Petrucci","sequence":"additional","affiliation":[{"name":"Lyon 1 University, Claude Bernard University \u00a0 Medical School, 69003 Lyon ,","place":["France"]},{"name":"Service D\u2019anatomopathologie, H\u00f4pital Lyon Sud, Hospices Civils de Lyon, 69495 Oullins-Pierre-Benite ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Descotes","sequence":"additional","affiliation":[{"name":"Service de Biochimie et de Biologie Mol\u00e9culaire, H\u00f4pital Lyon Sud, Hospices Civils de Lyon, 69495 Oullins-Pierre-Benite ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9517-338X","authenticated-orcid":false,"given":"G\u00e9rald","family":"Raverot","sequence":"additional","affiliation":[{"name":"Endocrinology Department, Reference Centre for Rare Pituitary Diseases HYPO, \u201cGroupement Hospitalier Est\u201d Hospices Civils de Lyon , 69500 Bron ,","place":["France"]},{"name":"Lyon 1 University, Claude Bernard University \u00a0 Medical School, 69003 Lyon ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Christophe","family":"Lifante","sequence":"additional","affiliation":[{"name":"Service de Chirurgie Endocrinienne, H\u00f4pital Lyon Sud, Hospices Civils de Lyon, 69495 Oullins-Pierre-Benite ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5725-0199","authenticated-orcid":false,"given":"Christophe","family":"Sajous","sequence":"additional","affiliation":[{"name":"Service D\u2019oncologie, H\u00f4pital Lyon Sud, Hospices Civils de Lyon, 69495 Oullins-Pierre-Benite ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Lopez","sequence":"additional","affiliation":[{"name":"Service de Biochimie et de Biologie Mol\u00e9culaire, H\u00f4pital Lyon Sud, Hospices Civils de Lyon, 69495 Oullins-Pierre-Benite ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Lasolle","sequence":"additional","affiliation":[{"name":"Endocrinology Department, Reference Centre for Rare Pituitary Diseases HYPO, \u201cGroupement Hospitalier Est\u201d Hospices Civils de Lyon , 69500 Bron ,","place":["France"]},{"name":"Lyon 1 University, Claude Bernard University \u00a0 Medical School, 69003 Lyon ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,5,31]]},"reference":[{"issue":"1","key":"2025060602215006200_lvaf105-B1","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s12022-022-09710-8","article-title":"Overview of the 2022 WHO classification of adrenal cortical tumors","volume":"33","author":"Mete","year":"2022","journal-title":"Endocr Pathol"},{"issue":"6","key":"2025060602215006200_lvaf105-B2","doi-asserted-by":"publisher","first-page":"E926","DOI":"10.1210\/jc.2014-4204","article-title":"ARMC5 mutations in a large cohort of primary macronodular adrenal hyperplasia: clinical and functional consequences","volume":"100","author":"Espiard","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2025060602215006200_lvaf105-B3","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s12022-023-09751-7","article-title":"Impact of morphology in the genotype and phenotype correlation of bilateral macronodular adrenocortical disease (BMAD): a series of clinicopathologically well-characterized 35 cases","volume":"34","author":"Violon","year":"2023","journal-title":"Endocr Pathol"},{"issue":"4","key":"2025060602215006200_lvaf105-B4","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1210\/endrev\/bnac034","article-title":"Clinical, pathophysiologic, genetic, and therapeutic progress in primary bilateral macronodular adrenal hyperplasia","volume":"44","author":"Bertherat","year":"2023","journal-title":"Endocr Rev"},{"issue":"8","key":"2025060602215006200_lvaf105-B5","doi-asserted-by":"publisher","first-page":"2930","DOI":"10.1210\/jc.2009-0516","article-title":"Clinical and genetic heterogeneity, overlap with other tumor syndromes, and atypical glucocorticoid hormone secretion in adrenocorticotropin-independent macronodular adrenal hyperplasia compared with other adrenocortical tumors","volume":"94","author":"Hsiao","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2025060602215006200_lvaf105-B6","doi-asserted-by":"publisher","first-page":"516","DOI":"10.20945\/2359-3997000000170","article-title":"Outcome and long-term follow-up of adrenal lesions in multiple endocrine neoplasia type 1","volume":"63","author":"Ventura","year":"2019","journal-title":"Arch Endocrinol Metab"},{"issue":"22","key":"2025060602215006200_lvaf105-B7","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1056\/NEJMoa1304603","article-title":"ARMC5 mutations in macronodular adrenal hyperplasia with Cushing's syndrome","volume":"369","author":"Assi\u00e9","year":"2013","journal-title":"N Engl J Med"},{"key":"2025060602215006200_lvaf105-B8","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.mce.2017.06.027","article-title":"The role of ARMC5 in human cell cultures from nodules of primary macronodular adrenocortical hyperplasia (PMAH)","volume":"460","author":"Cavalcante","year":"2018","journal-title":"Mol Cell Endocrinol"},{"issue":"2","key":"2025060602215006200_lvaf105-B9","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1097\/PAS.0000000000000943","article-title":"Diagnostic and prognostic biomarkers of adrenal cortical carcinoma","volume":"42","author":"Mete","year":"2018","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"2025060602215006200_lvaf105-B10","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/ng.2953","article-title":"Integrated genomic characterization of adrenocortical carcinoma","volume":"46","author":"Assi\u00e9","year":"2014","journal-title":"Nat Genet"},{"issue":"2","key":"2025060602215006200_lvaf105-B11","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.ccell.2016.07.013","article-title":"Comprehensive pan-genomic characterization of adrenocortical carcinoma","volume":"30","author":"Zheng","year":"2016","journal-title":"Cancer Cell"},{"issue":"2","key":"2025060602215006200_lvaf105-B12","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1530\/ERC-18-0385","article-title":"Somatic mutations in adrenocortical carcinoma with primary aldosteronism or hyperreninemic hyperaldosteronism","volume":"26","author":"Mouat","year":"2019","journal-title":"Endocr Relat Cancer"},{"key":"2025060602215006200_lvaf105-B13","doi-asserted-by":"publisher","first-page":"114088","DOI":"10.1016\/j.ejca.2024.114088","article-title":"Germline NGS targeted analysis in adult patients with sporadic adrenocortical carcinoma","volume":"205","author":"Scatolini","year":"2024","journal-title":"Eur J Cancer"},{"key":"2025060602215006200_lvaf105-B14","doi-asserted-by":"publisher","first-page":"115276","DOI":"10.1016\/j.ejca.2025.115276","article-title":"Letter Re: germline NGS targeted analysis in adult patients with sporadic adrenocortical carcinoma","volume":"218","author":"Bouys","year":"2025","journal-title":"Eur J Cancer"},{"issue":"1","key":"2025060602215006200_lvaf105-B15","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1093\/ejendo\/lvad066","article-title":"European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors","volume":"189","author":"Fassnacht","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"Supplement_1","key":"2025060602215006200_lvaf105-B16","doi-asserted-by":"publisher","first-page":"SAT-207","DOI":"10.1210\/jendso\/bvaa046.1943","article-title":"SAT-207 adrenocortical carcinoma in untreated congenital adrenal hyperplasia","volume":"4","author":"David","year":"2020","journal-title":"J Endocr Soc"},{"key":"2025060602215006200_lvaf105-B17","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.5049\/EBP.2007.5.2.140","article-title":"Adrenal tumors associated with inadequately treated congenital adrenal hyperplasia","volume":"9","author":"Wang","year":"2002","journal-title":"Can J Urol"},{"issue":"1","key":"2025060602215006200_lvaf105-B18","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1007\/s12020-018-1757-3","article-title":"18F-FDG PET reveals an adrenocortical carcinoma in a bilateral adrenal multinodular disease","volume":"63","author":"Lib\u00e9","year":"2019","journal-title":"Endocrine"},{"issue":"8","key":"2025060602215006200_lvaf105-B19","doi-asserted-by":"publisher","DOI":"10.1210\/jcemcr\/luae131","article-title":"Transformation of a benign adrenocortical adenoma to a metastatic adrenocortical carcinoma is rare but it happens","volume":"2","author":"Angelousi","year":"2024","journal-title":"JCEM Case Rep"},{"issue":"18","key":"2025060602215006200_lvaf105-B20","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1038\/onc.2010.614","article-title":"p16(Ink4a) overexpression in cancer: a tumor suppressor gene associated with senescence and high-grade tumors","volume":"30","author":"Romagosa","year":"2011","journal-title":"Oncogene"},{"issue":"8","key":"2025060602215006200_lvaf105-B21","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1093\/hmg\/ddq029","article-title":"Constitutive \u03b2-catenin activation induces adrenal hyperplasia and promotes adrenal cancer development","volume":"19","author":"Berthon","year":"2010","journal-title":"Hum Mol Genet"},{"issue":"7","key":"2025060602215006200_lvaf105-B22","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1530\/EC-20-0228","article-title":"Intratumor heterogeneity of prognostic DNA-based molecular markers in adrenocortical carcinoma","volume":"9","author":"Jouinot","year":"2020","journal-title":"Endocr Connect"},{"issue":"10","key":"2025060602215006200_lvaf105-B23","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1530\/ERC-21-0040","article-title":"Targeted genomic analysis of 364 adrenocortical carcinomas","volume":"28","author":"Pozdeyev","year":"2021","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"2025060602215006200_lvaf105-B24","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1158\/2159-8290.CD-12-0361","article-title":"ARID1A mutations in cancer: another epigenetic tumor suppressor?","volume":"3","author":"Wu","year":"2013","journal-title":"Cancer Discov"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ejendo\/advance-article-pdf\/doi\/10.1093\/ejendo\/lvaf105\/63409505\/lvaf105.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/192\/6\/K55\/63409505\/lvaf105.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/192\/6\/K55\/63409505\/lvaf105.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T06:21:58Z","timestamp":1749190918000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/192\/6\/K55\/8154265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,30]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,5,30]]}},"URL":"https:\/\/doi.org\/10.1093\/ejendo\/lvaf105","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,6]]},"published":{"date-parts":[[2025,5,30]]}}}